Package 80425-0539-1

{"route": ["ORAL"], "spl_id": "3d826804-6428-aae1-e063-6394a90a6593", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["3d826804-6427-aae1-e063-6394a90a6593"], "manufacturer_name": ["Advanced Rx of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80425-0539-1)", "package_ndc": "80425-0539-1", "marketing_start_date": "20250829"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80425-0539-2)", "package_ndc": "80425-0539-2", "marketing_start_date": "20250829"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80425-0539-3)", "package_ndc": "80425-0539-3", "marketing_start_date": "20250829"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "80425-0539_3d826804-6428-aae1-e063-6394a90a6593", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "80425-0539", "generic_name": "bupropion hydrochloride", "labeler_name": "Advanced Rx of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20250829", "listing_expiration_date": "20261231"}